Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
10,079 results
- ICT-HCTIndependent statistical analysis of Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ictal and Interictal Inflammatory Markers in Migraine: Complete Statistical AnalysisIndependent statistical analysis of Ictal and Interictal Inflammatory Markers in Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01138150).
- Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant: Complete Statistical AnalysisIndependent statistical analysis of Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ID11-56Independent statistical analysis of An Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- iDCLIndependent statistical analysis of The International Diabetes Closed Loop (iDCL) Trial: Protocol 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02985866).
- IDEAIndependent statistical analysis of Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04425863).
- IDEALEIndependent statistical analysis of Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study):…
- Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Identifying and Treating Depression in Hemodialysis Patients: Complete Statistical AnalysisIndependent statistical analysis of Identifying and Treating Depression in Hemodialysis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03390933).
- IDENTITY-2Independent statistical analysis of Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients: Complete Statistical AnalysisIndependent statistical analysis of IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02854059).
- iDIETIndependent statistical analysis of The Immune Directed Individualized Elimination Therapy (iDIET) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05543512).
- IDMPCIndependent statistical analysis of Improving Depression Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05050227).
- IETPPEIndependent statistical analysis of Investigations of Ear Tip Performance, Perceptions, and Experiences: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05725824).
- IF-AMDIndependent statistical analysis of Improving Function in Age-Related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00572039).
- IFUMIndependent statistical analysis of Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- IGF-1 and Bone Loss in Women With Anorexia Nervosa: Complete Statistical AnalysisIndependent statistical analysis of IGF-1 and Bone Loss in Women With Anorexia Nervosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01406444).
- iGlarLixi vs IDegAsp in Chinese Participants After OAD(s): Complete Statistical AnalysisIndependent statistical analysis of iGlarLixi vs IDegAsp in Chinese Participants After OAD(s): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05413369).
- IGNAZIndependent statistical analysis of Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- IHAIndependent statistical analysis of Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IKEEGIndependent statistical analysis of EEG Changes With Guided Online Meditation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03459690).
- IKEMAIndependent statistical analysis of Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients: primary endpoint results, effect estimate with confidence interval, sample-size…
- IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia: Complete Statistical AnalysisIndependent statistical analysis of IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00524342).
- IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT: Complete Statistical AnalysisIndependent statistical analysis of IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- IL-17 Neutrophils in CF Lung Inflammation: Complete Statistical AnalysisIndependent statistical analysis of IL-17 Neutrophils in CF Lung Inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02025829).
- IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA: Complete Statistical AnalysisIndependent statistical analysis of IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ILA115938Independent statistical analysis of Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Illness Management and Recovery for Veterans With Severe Mental Illness: Complete Statistical AnalysisIndependent statistical analysis of Illness Management and Recovery for Veterans With Severe Mental Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00515671).
- ILMARI2Independent statistical analysis of Impact of Adding a Limitation Section in Abstract of Systematic Review: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability: Complete Statistical AnalysisIndependent statistical analysis of Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- IMIndependent statistical analysis of Acetic Acid Chromoendoscopy to Judge Gastric Intestinal Metaplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01499576).
- IMAGEIndependent statistical analysis of A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Image Evaluation of Philips Philips MammoDiagnost DR Full Field Digital Mammography System (FFDM): Complete Statistical AnalysisIndependent statistical analysis of Image Evaluation of Philips Philips MammoDiagnost DR Full Field Digital Mammography System (FFDM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Image Guidance for Improved Vessel Cannulation in Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Image Guidance for Improved Vessel Cannulation in Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04031495).
- IMAGE-ACSIndependent statistical analysis of Improving Medication Adherence Through Graphically Enhanced Interventions in Acute Coronary Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis: Complete Statistical AnalysisIndependent statistical analysis of Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis: primary endpoint results, effect estimate with…
- Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis: Complete Statistical AnalysisIndependent statistical analysis of Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IMAGINEIndependent statistical analysis of Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IMAGINEIndependent statistical analysis of Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- IMAGINE 2Independent statistical analysis of A Study in Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01435616).
- IMAGINE 8Independent statistical analysis of A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence…
- Imaging Extrastriatal Dopamine Release in Tobacco Smokers and Nonsmokers: Complete Statistical AnalysisIndependent statistical analysis of Imaging Extrastriatal Dopamine Release in Tobacco Smokers and Nonsmokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02348385).
- Imaging in MGUS, SMM and MM: Complete Statistical AnalysisIndependent statistical analysis of Imaging in MGUS, SMM and MM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01237054).
- Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach: Complete Statistical AnalysisIndependent statistical analysis of Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- iMALTIndependent statistical analysis of Improving Medication Adherence in Adolescents Who Had a Liver Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03691220).
- IMARA-SA pilotIndependent statistical analysis of A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women: IMARA SA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- iMATRIXcobiIndependent statistical analysis of Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- IMBSRADQWIUAIndependent statistical analysis of Impact of Mindfulness Based Stress Reduction on Anxiety, Depression and QOL in Women With Intrauterine Adhesion.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases: Complete Statistical AnalysisIndependent statistical analysis of Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…